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Abstract. Cyclophilins (cyclosporin A-binding pro-
teins) are conserved, ubiquitous, and abundant pro-
teins that accelerate the isomerization of XaaPro pep-
tide bonds and the refolding of proteins in vitro.
s-Cyclophilin is a member of the cyclophilin family
with unique NH2- and COOH-terminal extensions, and
with a signal sequence. We now report that s-cyclo-
philin is retained in the cell, and that the conserved
s-cyclophilin-specific COOH-terminal extension
VEKPFAIAKE is sufficient to direct a secretory pro-
tein to s-cyclophilin containing structures.
Antibodies to s-cyclophilin-specific peptides were
produced and the location of the protein was deter-
mined by an immunocytochemical study at the light
microscopic level . s-Cyclophilin colocalized with the
Cat+-binding protein calreticulin and, to a lesser ex-
tent, with the microsomal Cat+ATPase in the myo-
genic cell line L6, and with the Cal+-binding protein
calsequestrin in skeletal muscle. In activated platelets,
s-cyclophilin immunoreactivity was detected in a ring-
like structure that might correspond to the Cal+-
storing and -releasing dense tubular network. In
spreading cells, s-cyclophilin containing vesicular
C
YCLOPHILIN is an ubiquitous, highly conserved, and
abundant 18-kD cytosolic protein (Hohman and
Hultsch, 1990; Stamnes and Zuker, 1990). In vitro,
it greatly accelerates the isomerization of Xaa-Pro peptide
bonds (Fischer et al., 1989; Takahashi et al., 1989) . This
observation led to the proposal that the peptidyl-prolyl cis-
trans isomerase activity of cyclophilin may enable it to pro-
mote protein folding (Fischer and Schmid, 1990).
The function of cyclophilin in vivo is presently not clear,
but indirect evidence suggests that it might be involved in
Call-mediated signal transduction processes. Thus cy-
clophilin is a major cellular target of the immunosuppressant
cyclosporin A (CsA)I, a potent inhibitor of several Caz+-
mediated responses (Hohman and Hultsch, 1990). CsA
1. Abbreviations usedin thispaper: CsA, cyclosporin A; GDN, glia-derived
nexin; KLH, keyhole lympet hemocyanin.
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structures accumulated at actin-rich protrusion sites.
While s-cyclophilin consistently codistributed with
Cat+ storage site markers, the distribution of
s-cyclophilin immunoreactivity was not identical to
that of ER markers.
To determine whether the COOH-terminal extension
of s-cyclophilin was involved in its intracellular trans-
port we added this sequence to the COOH-terminus of
the secretory protein glia-derived nexin. Appropriate
constructs were expressed transiently in cultured cells
and proteins were detected with specific antibodies.
We found that glia-derived nexin with the 000H-
terminal sequence VEKPFAIAKE (but not with the
control sequence GLVVMNIT) colocalized with en-
dogenous s-cyclophilin, indicating that the sequence
contained retention information. These results indicate
that s-cyclophilin is a retained component of an intra-
cellular organelle and that it may accumulate in
specialized portions of the ER, and possibly in calcio-
somes. Because of its conserved structure, widespread
distribution, and abundance s-cyclophilin may be a
useful marker to study the biogenesis and distribution
of ER subcompartments.
blocks the enzymatic activity of cyclophilin. The best-
studied action of CsA is its suppression of T-helper lympho-
cyte activation, leading to immunosuppression. In lympho-
cytes, CsA blocks the transcriptional activation of a subset
of genes essential for the activation process. The affected
genes are apparently all activated by signaling pathways in-
volving Call (Trenn et al., 1989; Mattila et al ., 1990). CsA
is also a potent inhibitor of several regulated secretion pro-
cesses, where it has been shown to interfere with Cal+ sig-
naling, rather than with the exocytosis process itself (Cirillo
et al., 1990; Hultsch et al., 1990) . Finally, CsA blocks the
activation of a Cal+-conducting pore in mitochondria, prob-
ably because of its binding to a mitochondrial matrix-asso-
ciated cyclophilin (Halestrap and Davidson, 1990 ; McGui-
ness et al., 1990). Interestingly, the cellular target of the
structurally unrelated immunosuppressant FK-506 is a cyto-
solic protein that does not resemble cyclophilin in structure,a
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but thatpossesses similar peptidyl-prolyl isomerase activity
(Standaert et al ., 1990 ; Tropschug et al ., 1990) . FK-506
blocks the enzymatic activity ofthe FK-506-binding protein .
Cytosolic cyclophilins with highly homologous structures
have been found in eukaryotes from man to yeast, and in
bacteria (Hohman and Hultsch, 1990 ; Stamnes and Zuker,
1990) . In addition, a mitochondrial cyclophilin has been de-
scribed in Neurospora crassa, where alternative splicing of
a mitochondrial-localization sequence yields two cellular cy-
clophilins from one single gene (Tropschug et al ., 1988) .
Additional genes coding for cyclophilins with a signal se-
quence have been described in yeast (Koser et al ., 1990) and
in Drosophila (Schneuwly et al., 1989 ; Shieh et al ., 1989) .
While the yeast variant has not been further characterized,
the Drosophila variant is encoded by the mutated gene in
photoreceptor-deficient ninaA flies . NinaA is a tissue-spe-
cific, integralmembrane cyclophilin-like protein required for
the proper synthesis of a subset of Drosophila rhodopsins
(Stamnes et al ., 1991) .
We have recently reported the identification of chick s-cy-
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Figure 1. Specificity of antisera to s-cyclophilin specific peptides .
(a) Comparison of human (Spik et al ., 1991; Price et al ., 1991),
rat (Iwai and Inagami, 1990), and chick (Caroni et al., 1991)
s-cyclophilin (s-cyph), and human cytosolic cyclophilin sequences .
s-Cyclophilin specific sequences used for the production of anti-
bodies are boxed . Signal peptide sequences are printed in small
characters . The published rat s-cyclophilin sequence extends for 23
amino acids from the indicated COOH-terminal end . However,
since it is almost identical to human and chick s-cyclophilin, and
since the corresponding nucleotide sequence would possess a stop
codon, but for a one-base insertion at nucleotide 684, we assumed
that rat s-cyclophilin does stop at Glu2os . (b) Detection of s-cyclo-
philin with antisera to s-cyclophilin specific peptides . Purified
recombinant signal peptide-free human s-cyclophilin (100 ng) was
fractionated and blotted . Blots were then either stained with amido
black to detect protein (lane 1, in this case 1 ug) or reacted with
antibodies to : (lane 2) a mixture of the three uncoupled s-cyclophilin specific peptides ; (lane 3) non-immune mouse serum; (lane 4)
NH2-terminal peptide ; (lane S) internal peptide ; (lane 6) COOH-terminal peptide. Unless indicated, the peptides were coupled to KLH
for immunization . Antisera were diluted 1:200, except in (lane 2), where the antiserum to the mixture of uncoupled peptides was diluted
1:2,000. (c) Specific detection of s-cyclophilin with anti-peptide mixture antiserum . 100 ug of L6 cell homogenate protein were separated
by SDS-PAGE, blotted, and reacted with 1:2,000 dilutions of either s-cyclophilin antiserum (lane 1) or nonimmune mouse serum (lane
2) .A few major Coomassie-staining bands were detected with all sera, but only s-cyclophilin (arrow)was detected with the immune serum .
Marks indicate migration position of 68, 31, 21, and 14-kD standards .
clophilin, a cyclophilin-like protein with an N11 2-terminal
signal sequence (Caroni et al ., 1991) . Cytosolic cyclophilin
and s-cyclophilin are transcribed from separate genes in
the chick genome, and s-cyclophilin mRNA was ubiquitous
and abundant throughout chick development . When overex-
pressed with the baculovirus system, a significant proportion
of the recombinant s-cyclophilin was secreted by infected in-
sect cells (Caroni et al ., 1991) . Almost identical proteins
were also identified in man (Spik et al., 1991 ; Price et al .,
1991 ; Hasel et al ., 1991), mouse (Hasel et al ., 1991), and
rat (Iwai and Inagami, 1990) . Like cytosolic cyclophilin, hu-
man s-cyclophilin possesses peptidyl-prolyl cis-trans isom-
erase activity, and binds CsA with high affinity, indicating
thatthe two proteins are also functionally related (Spiket al .,
1991 ; Price et al., 1991 ; Hasel et al., 1991) . The sequences
of human, mouse, rat, and chick s-cyclophilin are almost
identical in regions where these secretory forms differ in se-
quence from the cytosolic forms . There are three conserved
s-cyclophilin specific sequences : (a) a seven amino acid large
highly charged N112-terminal extension ; (b) a 10-residue
MKVLLAAALIAGSVFFLLLPGPS DEKKKG?KVTVKVYFDLRIGDEDVGRVIFGLFGKTVPKTVDNFVALATGEKGFGYKNS
----F-----V---V--------V ND--------------FQ--GRTCRTSDLWTLW-DCS---------------------
MKA-V--TAL-PALL----AA-R] --R-------p,--F----V-E--A---VI-----------E----------- --F-G-
M-NPT-E--IAVDG-PL---S-E--ADK----AE--R--S----- ---G--Figure 2. Antibodies to non-overlapping s-cyclophilin specific peptides detect similar intracellular vesicular structures. PermeabilizedL6
cells were stained with antisera to the following antigens : (a) KLH-coupled N112-terminal peptide ; (b) KLH-coupled COOH-terminal
peptide; (c) uncoupled peptide mixture (all three peptides) ; (d) non-immune mouse serum. Bar, 15 Am .
stretch of high surface probability in the COOH-terminal
half of the shared cyclophilinsequence ; and (c) a 10-residue
COOH-terminalextension. The COOH-terminal extensions
are identical in chick, mouse, rat, and human s-cyclophilin
butdo not resemble the long COOH-terminal extension that
carriesthe hydrophobic sequence responsiblefor membrane
anchoring of the ninaA gene product.
In the present study we have localized s-cyclophilin in the
cell and identified sequences important for localization.
s-Cyclophilin is an intracellularly retained protein, and it
colocalizes with calreticulin (Krause et al ., 1989), and to a
lesser extent with microsomal Call-ATPase and SR calse-
questrin, i.e ., with calcium-binding ER and calciosomal
proteins (Hashimoto et al ., 1988 ; Volpe et al ., 1988 ; Mel-
dolesi et al ., 1990) . On theother hand, s-cyclophilin andER
antibodies (Louvard et al ., 1982 ; Bole et al ., 1986) yielded
different labeling patterns. The unique COOH-terminal ex-
tension of s-cyclophilin is necessary to direct it to its intra-
cellular location and is sufficient to efficiently sort a secre-
tory protein to the same intracellular compartment .
Materials andMethods
Reagents and Cells
Cycloheximide, tunicamycin, and lucifer yellow-CH were from Fluka
(Buchs, Switzerland) . Calcium-ionophore A231ß7 was from SigmaChem-
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ical Co . (St . Louis, MO). TRITC-phalloidin was a gift of Dr. K. Ballmer
(Friedrich Miescher Institute, Basel, Switzerland) . C&A(stock solution of
20 mg/ml in ethanol) wasa kind gift of Dr. S . Alkan (Ciba-Geigy, Basel,
Switzerland) . Oligonucleotides were synthesized using a 308B DNA syn-
thesizer (AppliedBiosystems Inc., FosterCity,CA). The glia-derived nexin
(GDN) full-length clone was a kind gift of Dr. D . Monard (Friedrich
Miescher Institute, Basel, Switzerland) . Signal peptide-free recombinant
human s-cyclophilin (Ala2S to GIUZ08) was expressed and purified from
Escherichia coli according to standard techniques (Hasan and Szybalski,
1987) .
Rabbit antiserum to ER membrane proteins (Louvard et al ., 1982)was
a gift of Dr. D . Louvard (Pasteur Institute, Paris, France) . mAb to Gí/93
antigen (Schweizer et al ., 1988)was a gift of Dr. H.-P. Hauri (Biocenter,
University ofBasel, Switzerland) . Rabbit antiserum to chick calsequestrin
(Choi and Clegg, 1990) was a gift ofDr. D . Clegg, (University ofCalifor-
nia, Santa Barbara, CA). Chicken antiserum to rat GDN (Halfter et al .,
1989) was a gift of Dr. D . Monard (Friedrich Miescher Institute, Basel,
Switzerland) . Rabbit antiserum to peptideGLWMNTT(internal sequence
ofthe extracellular matrix proteintenascin) detected this peptide only when
it was located at the C0011-terminal. end ofproteins,andwasa gift of Dr.
R. Chiquet-Ehrismann (Friedrich Miescher Institute) . Antibodies against
human calreticulin andhumanCaZ+ATPase were produced by immuniza-
tion of rabbits with synthetic peptides coupled to keyhole limpet hemocya-
nin(KLH) (Sigma Chemical Co.) . The20 N112-terminal amino acids were
deduced from the cDNA sequence (Cal'-ATPase) or from protein se-
quence andcDNA cloning (calreticulin) . The antibodies used in this study
specifically detected their respective antigens on Western blots . FITC- and
TRITC-coupled goat anti-mouse, and goat anti-rabbit were from Milan
Analytica (LaRoche, Switzerland) . TRITC-coupled goat anti-chicken IgG
was from Jackson Immuno Research Laboratories Inc . (Avendale, PA).
Cell lines were cultivated in DMEwith 10% FCS . Monkey kidney epi-
thelial cells (COS-7), and rat myogenic L6 cells were from American TypeFigure 3. Distribution of s-cyclophilin in crude subcellular frac-
tions . s-Cyclophilin was detected on Western blots with antiserum
to the uncoupled peptide mixture . (a) Rat liver fractions. 100 I~g
of the following crude protein fractions were applied to the gel :
(lane 1) homogenate ; (lane 2) high-speed supernatant ; (lane 3)
microsomes ; (lane 4) mitochondria ; (lane 5) nuclei . s-Cyclophilin
was enriched in the microsomal fraction. (b) Bovine anterior pitu-
itary membrane fractions . 100 Wg ofcrude low-density membranes
(lane 1), and of purified secretory granules (lane 2) were applied
to the gel . s-Cyclophilin was notdetected in secretory granules . (c)
Microsome associated s-cyclophilin comigrates with mature re-
combinant human s-cyclophilin . Samples contained 50 Pg of rat
liver microsome protein plus 100 ng of pure recombinant s-cyclo-
philin (lane 1), 50 jig of liver microsomes (lane 2), and 100 ng of
pure recombinant s-cyclophilin (lane 3) . The estimated migration
position of recombinant s-cyclophilin with signal peptide (plus
2 .7 kD is indicated by the bar.
Cell Culture (Rockville, MD) . Human platelets were cultivated in 137mM
NaCl, 2 .6 mM MgCIZ, 5.5mM glucose, 15mM Hepes, pH 7.4 (101 plate-
lets/ml), activated by substrate contact, and examined 30 min after acti-
vation .
Production ofAntibodies to s-Cyclophilin
The following s-cyclophilin specificpeptides were synthesized and purified:
DERKKGPKVTAKY (NH Z-terminal extension after signal peptide cleav-
age), RKVENTKTDSRDY (internal sequence ofhigh surface probability),
YTIEVEKPFAIAKE (COOH-terminal extension) . The peptides were
separately coupled to KLH with bis-diazo-benzidine (2 h, 4°C reactions;
2 mg/mlofKLH, 0.1 mg/ml ofpeptide) (Doolittle, 1986) . 6-wk-oldBALB/c
mice were immunized either with 100 Wg of each KLH-coupled peptide
separately, or with 200 Wg of an equimolar mixture ofthe three uncoupled
peptides . The first i.p. injection in complete Freund's adjuvant was followed
by boosts after 3 and after 5 wk (100 Ag of antigen in incomplete Freund
adjuvant) . Sera were collected and tested 5 d after the second boost. Ini-
tially, antisera were tested by ELISA and on Western blots with BSA
(Sigma)-coupled peptide as the antigen . Positive antibodies were further
tested for detection of non-denatured purified recombinant human s-cyclo-
philin on ELISA, and for the specific detection of s-cyclophilin on Western
blots ofrecombinant baculovirus infected Sf9 cell homogenate, and of rat
myogenic L6 cell homogenate . All four immunization protocols produced
antibodies that satisfied these criteria . The best antibodies forWestern blots
were obtained with the uncoupled peptide mixture as antigen, whereas the
best antibodies for immunocytochemistry experiments were against the in-
ternal peptide coupled to KLH .
Immunocytochemistry
Chick tissues were fixed overnight at 4°C in 4% paraformaldehyde in PBS,
cryoprotected by a 4-6-h incubation in PBS with 20% sucrose at 4°C, cut
in 12-jAm sections on a cryostat (Carl Zeiss, Zurich, Switzerland), and sec-
tions were collected on subbed cover slides . All further incubations were
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carried out at room temperature . Non-specific-binding sites were blocked
by a 30-min incubation in PBS with 5% BSA and 0.1% NP-40 (Sigma
Chemical Co.), and further incubations were as described fortissue culture
cells. Cultured cells were fixed for 30 min at room temperature in freshly
prepared 4% paraformaldehyde in PBS . Fixative was then removed, cells
wererinsedin PBS, andpermeabilizedby incubating for 10min in PBSwith
0.1% NP-40. Non-specific-binding sites were blocked by a 30-min incuba-
tion in PBS with 5 % BSA . Subsequentprocedures were carried out in a ba-
sic medium consisting of PBS with 5% BSA . Cells were treated with
1:200-1:500dilutionsofanti-s-cyclophilin antibodies, with orwithoutaddi-
tional antibodies as indicated. Unbound antibodies were then removed, and
cells were exposed to 1:100 dilutions ofthe appropriate fluorescent second
antibodies (alone or incombination, as indicated) . Afterextensive washing,
cultures were mountedin Gelvatol(Monsanto, St . Louis, MO), andfluores-
cence was detected with an Axiovert-10 microscope (Carl Zeiss) equipped
with the appropriate filters for independent detection of FITC and of
TRPrC . Variant protocols included fixation and permeabilization in metha-
nol/acetone (1 :1) for 3 min at room temperature, or the inclusion of 0.1%
saponin in all incubation buffers. Control experiments with appropriate
non-immune antisera were routinely performed to verify the specificity of
the signals . For double-labeling experiments, appropriate control experi-
ments were performed to verify that specific independent labeling was de-
tected .
Zh detect endocytotic compartments, cells were incubated for periods of
5-60 min in 10 mg of lucifer yellow per nil of culture medium (Swanson
et al ., 1985 ; Brown et al ., 1986), washed on ice, fixed, and processed for
immunocytochemistry as described above. F-actin was detected with FITC-
phalloidin (Sigma Chemical Co.) . N-linked glycosylation was blocked by
the addition of0.5 pg/ml oftunicamycin to the culture medium for aperiod
of 18 h . For protein synthesis blocking experiments, 0.1 wglml ofcyclohexi-
mide were added to the culture medium; cells were incubated in inhibitor
containing mediumfor periods ofup to 6h, andthenprocessed for immuno-
cytochemistry as described above. In temperature block experiments, cells
were incubated at 20°C for 3 h, and then fixed and labeled as described
above . Where indicated 7 tLM ofA23187 was included in the culture me-
dium for a period of 3 h before fixation .
7ransfection Experiments
Mutant s-cyclophilin andGDN sequences were produced by the polymerase
chain reaction, with appropriate primers. Briefly, homologous five prime
end sense primers wereused in combination with partially overlapping mu-
tant three prime antisense primers in three consecutive reactions that pro-
gressively produced the complete, mutated three prime sequence. Products
were cloned into appropriate vectors for double-stranded sequencing with
SP6 and T7 primers, using the chaintermination method andthe Sequenase
2 kit (United States Biochemicals Corp., Cleveland, OH) . Inserts with the
mutated sequence were cloned directionally into the eukaryotic expression
vector pECE (Ellis et al ., 1986), plasmid DNA was isolated, and trans-
fected into L6 or COS-7 cells with the calcium-phosphate precipitation
method (Chen and Okayama, 1987) . Cells wereexposed to aglycerol shock
16 h after transfection, fixed 48 h after transfection, and finally processed
for immunocytochemistry as described above. Transfection efficiencies
ranged from 1-5% .
OtherMethods
Rat liver subcellular fractions were isolated by a procedure that had been
specifically devised to yield Cat+ transport competent microsomes
(Dawson, 1982) . Bovine adrenal medulla derived secretory granules were
prepared as described (Schweizer et al ., 1989) .
SDS-PAGE fractionation andWestern blot analysis ofprotein containing
fractions were performed according to standard methods . Bound antibody
was detected with alkaline phosphatase-coupled goat anti-mouse (Milan
Analytica, LaRoche, Switzerland) .
Protein amounts were determined by the filter binding assay (Schaffner
and Weissman, 1973), with BSA (Sigma Chemical Co .) as a standard .
Results
s-Cyclophilin Isan Ubiquitous Intracellularly
Retained Protein: Colocalization with theERand
CalciosomalProtein Calreticulin
s-Cyclophilin possesses a classical signal sequence and issecreted from cells (Caroni et al., 1991; Spik et al., 1991) .
The N112-terminal end of s-cyclophilin isolated from human
milk begins at Ala2s, indicating that the signal sequence of
s-cyclophilin is functional (Spik et al., 1991). We noticed
however, that even in insect cells that had been infected with
recombinant baculovirus and that were therefore massively
overexpressing s-cyclophilin, only -60% of the newly syn-
thesized protein was secreted, and that most of that secretion
had taken place within the first 30 min after synthesis
(Caroni et al., 1991) . This suggested to us that a significant
proportionof the protein was removed from the export path-
way, indicating that the prevalent location of s-cyclophilin
might be intracellular.
To determine the cellular location of s-cyclophilin we
produced antibodies to conserved, nonoverlapping s-cyclo-
philin-specific peptides (Fig. 1 a). As shown in Fig. 1 a,
the peptides did not overlap with cytosolic cyclophilin se-
quences, thus excluding crossreactivity of the antibodies
with this related protein. Antisera to three different peptides
all bound s-cyclophilin on Western blots (Fig. 1 b) . The
NH2-terminal peptide produced weak antibodies for immu-
noblot experiments (Fig. 1 b, lane 4) and for ELISA, but
importantly, all antisera detected vesicle-like structures of
similar distribution in permeabilized L6 myogenic cells(Fig.
2, a and b). An antiserum produced against a mixture of the
three uncoupled peptides yielded similar results (Fig. 2 c),
demonstrating that the antibodies did not detect a shared epi-
tope that had been produced in the process of coupling the
peptides to KLH. The peptide mixture antiserum gave the
strongest signals on immunoblots and was therefore used for
most such experiments. The specific detection of s-cyclo-
philin in L6 cell homogenates (immunoblot data, Fig. 1 c)
and the essential identity of the immunocytochemical results
obtained with all antibodies to s-cyclophilin peptides (Fig. 2,
see also Fig. 4) led us to conclude that the antibodies spe-
cifically bind s-cyclophilin in the immunocytochemical ex-
periments.
The experiments shown in Fig. 2 did not reveal a Golgi-
like pattern of immunoreactivity, and therefore suggested
that a significant proportion of s-cyclophilin might be re-
tained in intracellular vesicular structures. To obtain an esti-
mate of s-cyclophilin contents in subcellular fractions, crude
fractions ofnuclei, mitochondria, microsomes, and of solu-
ble proteins were prepared from rat liver homogenate. As
shown in Fig. 3 a, while s-cyclophilin was recovered in all
crude membrane fractions, this protein was enriched in
the microsomal fraction. On the other hand, low levels of
s-cyclophilin were detected in a non-membrane-associated
soluble protein fraction. Also shown in Fig. 3 are Western
blot data of adrenal medulla derived membrane fractions :
high levels of s-cyclophilin were detected in a low density
membrane fraction but no s-cyclophilin was foundassociated
with secretory granules (Fig. 3 b). In a recent study, Sutcliffe
and colleagues (Hasel et al., 1991) have determined the as-
sociation of s-cyclophilin (called cyclophilin-2 in that study)
with purified subcellular fractions by immunoblot analysis.
These authors coulddemonstrate that s-cyclophilin is nearly
exclusively associated with ER-enriched fractions. Our re-
sults indicate that tissue s-cyclophilin tends to codistribute
with low-density membrane-bound structures. That s-cyclo-
philin was actually located inside these structures in situ is
indicated by the Western blot data shown in Fig. 3 c: micro-
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some-associated rat s-cyclophilin and recombinant human
s-cyclophilin that had been expressed in E. coli as a signal
peptide-free protein had very similar apparent molecular
weight (difference of less than 0.4 kD, i.e., much less than
the 2 .7 kD difference predicted for the signal peptide of
s-cyclophilin) . E. coli-derived recombinant s-cyclophilin
was not glycosylated, and the apparent molecular weight of
L6 cell s-cyclophilin was not affected by the inhibitor of
N-linked glycosylation tunicamycin (data not shown). There-
fore, microsome-associated s-cyclophilin has lost its signal
sequence, and hence reached the compartment after trans-
location across the ER membrane.
To localize s-cyclophilin-containing membrane-bound
structures in the cell, we performed double-labeling experi-
ments at the lightmicroscopic level. The endocytotic pathway
was labeled by incubating cells in a lucifer yellow derivative,
which is a marker for bulk phase endocytosis (Swanson et
al. 1985 ; Brown et al., 1986) . Cells were then fixed and
reacted with s-cyclophilin specific antibody. No overlap
between the early endocytotic pathway (5-min uptake) and
s-cyclophilin positive structures couldbe detected (Fig. 4 a).
Negative results were also obtained when later endocytotic
structures were visualized by the lucifer yellow method (data
not shown). We conclude, therefore, that s-cyclophilin is not
sorted to components ofthe endocytotic pathway, and that it
does not accumulate in cells by reentering these after secre-
tion . When cells were treated with the inhibitor of protein
synthesis cycloheximide, s-cyclophilin immunoreactivity
only declined very slowly (see Fig. 4 c; little change was ob-
served after6 h, data not shown), indicating that this protein
has a long half-life in the cell, and suggesting that most of
it does not reach the constitutive secretory pathway. This in-
terpretation was also supported by temperature block experi-
ments, where exit of proteins from the trans-Golgi was in-
hibited by incubating the cells at 20"C for 3 h: as shown in
Fig. 4 d, the distribution of s-cyclophilin was apparently not
affected by the temperature block, indicating that it did not
pass the trans-Golgi compartment to reach its intracellular
location.
We then compared the distribution of s-cyclophilin with
that of the ER: for this purpose, we used an antiserum
directed against ER membrane antigens (Louvard et al.,
1982) . As shown in Fig. 4, e-h, a pattern resembling that
of s-cyclophilin was obtained. However, the typical reticular
structure obtained with the ER antiserum was never ob-
served with s-cyclophilin antibodies. In addition, while the
overall distribution of ER and s-cyclophilin immunoreac-
tivity were comparable, s-cyclophilin-containing vesicular
structures frequently did not overlap with ER signal, and oc-
casional peripheral reticular structures did not overlap with
s-cyclophilin "spots". Similar results were obtained when the
ER was visualized with a mAb against the soluble lumenal
ER protein, BiP (Bole et al., 1986) (data not shown). In con-
trast, we found that s-cyclophilin and the calcium storage
protein calreticulin (Smith and Koch, 1989; Treves et al.,
1990; Milner et al., 1991) had very similar distributions
(Fig. 5 a-f). Both calreticulin- and s-cyclophilin-containing
structures accumulated in the vicinity of the nucleus in the
presence ofthe microtubule depolimerizing drug nocodazole
(3 h of treatment, Fig. 5, c and d), and were little affected
by the calcium ionophore A23187 (3 h of treatment, Fig. 5,
e andf). The localization ofs-cyclophilin was also comparedFigure 4 . s-Cyclophilinis notdetected in early endocytotic compartments, nordoes it codistribute withERantigens. (a and b) s-Cyclophilin
is not detected in early endocytotic compartments. Cells were exposed to lucifer yellow for5 min, washed, fixed, and reacted with s-cyclo-
philin antibody (internal peptide) . Double-labeling experiment : (a) lucifer yellow ; (b) s-cyclophilin detected with TRITC-anti-mouse .
Threeendosomesand the corresponding position on the s-cyclophilin micrograph are indicated by the arrows . (c and d) The distribution
of s-cyclophilin immunoreactivity is not affected by a 2-h incubation in the presence of the inhibitor of protein synthesis cycloheximide
(c), nor by a 3-h incubation at 20°C (d). s-Cyclophilin was detected with the internal peptide antiserum in (c), and with the uncoupled
peptidemixture antiserum in d. (e-h) Double-labeling experiments to compare the distribution of theER (e and g) to that of s-cyclophilin
containing vesicle-like structures (fandh). ER was visualized with an established antiserum, and s-cyclophilinwas detected with the inter-
nal peptideantiserum . To facilitate comparison of the two distributions, arrows indicate corresponding positions in (g and h) . All experi-
ments were performed in L6 cells . Bars : 12 t.m .
The Journal of Cell Biology, Volume 116, 1992
￿
118FigureS s-Cyclophilin codistributes with theER calcium-binding proteins calreticulin andCallATPase. (af) Codistributíon ofcalretic-
ulin (a, c, and e) and of s-cyclophilin (b, d, andf) in L6 cells . Double-labeling experiments were performed on untreated control cells
(a and b), on cells that had been exposed to the micrombule depolimerizing drug nocodazole for 3 h (c and d), and on cells that had
been exposed to the calcium ionophore A23187 for 3 h (e andf) . Arrows in (c and d) indicate the edge of the cells : in the presence of
nocodazole, calreticulin, and s-cyclophilin immunoreactivity was concentrated in the vicinity of the nucleus. (g and h) : Cat+-ATPase (g)
and s-cyclophilin (h) in L6 cells. Arrows point to a vesicle-like structure that was not detected with the s-cyclophilin antibody. Bars : 15,um .
to that of microsomal Cat+ATPase (Campbell, 1986 ; Bur-
goyne et al ., 1989 ; Kaprialian et al ., 1989) . Asshownin Fig .
5, g and h, the labeling pattern with the Caz+ATPase anti-
body was spotted and the two proteins had similar distribu-
tions . However, calciumATPase and s-cyclophilin spots
frequently did not overlap, suggesting that the two proteins
may colocalize only partially. A similar conclusion was
Arber et al . Ubiquitous ER Protein s-Cyclophilin
reached when the distributions of s-cyclophilin and of the
sarcoplasmic reticulum cisternae-associated Cal+-binding
protein calsequestrin (Jorgensen et al ., 1983 ; Campbell,
1986; Fliegel et al., 1987; Choi and Clegg, 1991) were com-
pared (see Fig. 7,fand g) : similar labeling patterns were ob-
tained, but prominent spots of calsequestrin immunoreac-
tivity were not emphasized by the s-cyclophilin antibody. WeThe Journal of Cell Biology, Volume 116, 1992
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120therefore concluded that s-cyclophilin is an ER protein,
where its distribution resembles most closely that of the
calcium-binding protein calreticulin.
TheConserveds-Cyclophilin-specific
COON-TerminalAminoAcidExtension Contains
Intracellular Localization Information
The soluble ER protein calreticulin possesses the 000H-
terminal ER retention sequence KDEL (Munro and Pelham,
1987; Pelham, 1989) ; this sequence is not found in the solu-
ble protein s-cyclophilin which shows a similar distribution.
On the other hand, s-cyclophilins in man, mouse, rat, and
chick possess identical COOH-terminal extensions VEKP-
FAIAKE, extending from the highly conserved stop signal
ofthe cytosolic cyclophilins (Fig. 1 a). In addition, the mem-
brane bound cyclophilin-like protein encoded by the ninaA
gene in Drosophila possesses a (different) COOH-terminal
extension that includes a hydrophobic membrane anchoring
sequence (Stamnes et al., 1991). We therefore performed ex-
periments to determine whether the COOH-terminal exten-
sion of s-cyclophilin was required for its intracellular loca-
tion and, if so, whether it could affect the intracellular
transport of a secretory protein. In a first series of experi-
ments we replaced the wild-type COOH-terminal sequence
of s-cyclophilin with the sequence GLVVMNIT, to which a
specific antibody was available. This allowed us to detect
mutant (anti-GLVVMNIT antibody) and wild-type s-cyclo-
philin (antibody to s-cyclophilin COOH-terminal peptide)
independently from each other. When the mutant s-cyclo-
philin (s-cyclophilin-GLWMNIT) was expressed in L6 cells,
it was retained in the reticular structures characteristic ofthe
ER, possibly because it failed to fold properly (Pelham,
1989; Rothman, 1989) (Fig. 6, a and b). However, when the
fate of newly synthesized s-cyclophilin-GLVVMNIT was
visualized by the addition of cycloheximide to the culture
medium to block further protein synthesis, a Golgi-like pat-
tern of immunoreactivity tended to appear, suggesting that
s-cyclophilin-GLVVMNIT did eventually reach the secre-
tory pathway (data not shown). At no time, and irrespective
of whether the cells were treated or not with cycloheximide,
did s-cyclophilin-GLVVMNIT colocalize with wild-type
s-cyclophilin.
We then determined whether the sequence VEKPFAIAKE
couldby itself affect the sorting ofa soluble secretory protein
by transferring it to the COOH terminus of GDN, a potent
inhibitor of serine proteases with neurite promoting activity
(Guenther et al ., 1985) . GDN was selected because it was
known from cristal structure data that its COOH terminus
was probably exposed to the surface of the protein, where
it did not appear to interact with other residues, implying
that it might not be essential for proper folding of GDN in
the ER. For these experiments, monkey kidney epithelial
(COS-7) cells had to be transfected because L6 cells con-
tained relatively high levels of endogenous GDN, thus com-
plicating the specific detection of recombinant protein.
When GDN-GLWMNIT was transfected into GDN-neg-
ative COS-7 cells, the intracellular recombinant protein was
mainly detected in the Golgi area (Fig. 6 c), indicating that,
like wild type GDN, it displayed the typical behavior of
a secretory protein (Halfter et al., 1989). A substantial
amount of GDN-GLWMNIT was detected in reticular struc-
tures (Fig. 6 c), possibly reflecting slow exit of mutant pro-
tease inhibitor from the ER. Importantly, GDN-GLWMNIT
did not codistribute with endogenous s-cyclophilin (Fig. 6,
e andf) . Therefore, GDN-GLVVMNIT appeared to behave
like a less efficiently folding, butotherwise unaltered GDN. A
very different result was obtained when GDNVEKPFAIAKE
was transfected into COS-7 cells. In this case, no reticular
ER and no Golgipattern were observed: instead, the mutant
protein was localized to vesicular structures that tended to
accumulate in the vicinity of the nucleus, but could also be
detected in the periphery of the cell (Fig. 6 d) . When these
cells were counterstained for s-cyclophilin with the internal
peptide detecting antibody, thereby excluding any crossreac-
tivity with GDNVEKPFALAKE, a good correspondence of
the signals was observed (Fig. 6, g and h). Therefore, the
COOH terminus sequence VEKPFAIAKE was sufficient to
drastically alterthe intracellular transport ofGDN, directing
the mutant protein to s-cyclophilin containing structures.
s-Cyclophilin in ERfree Structures: Plateletsand
PseudopodiaofSpreadingCells
We have evaluated the distribution range of s-cyclophilin by
performingWestern blot analysis ofchicken, rat, and bovine
tissues, and by immunocytochemistry of frozen sections of
chick tissue, and ofvarious human, monkey, rat, and chicken-
derived cellsand cell lines. These experiments led us to con-
clude that s-cyclophilin is a fairly abundant, conserved and
ubiquitous protein (data inpart not shown) . Importantly, an-
tibodies to non-overlapping s-cyclophilin-specific peptides
detected a protein of same apparent molecular weight and/or
localization. Therefore, anti-s-cyclophilin antibodies are
valuable reagents to study the distribution of ER components
in many, and possibly in all types of mammalian and bird
cells (lower vertebrates were not tested).
Because CsA was consistently found to interfere with
processes involving calcium, and because s-cyclophilin
colocalized with ER Cal+-binding proteins, we analyzed
s-cyclophilin immunoreactivity in cellular structures known
to be sitesofelevated calcium accumulation and release, i.e.,
Figure 6. The s-cyclophilin specific COOH-terminal sequence VEKPFAIAKE can direct a secretory protein to s-cyclophilin containing
vesicular structures. Proteins with mutated COOH-terminal sequences were expressed transiently in L6 (a and b) and in COS-7 (c-h)
cells. (a and b) s-Cyclophilin-GLVVMNIT transfection: double labeling for recombinant mutated protein with anti-GLVVMNIT antiserum
(a), and for endogenous wild-type protein with internal peptide antiserum (b). s-Cyclophilin-GLVVMNIT accumulated in the ER. (c and
d) Comparisonofthe distributions of GDN-GLVVMNIT (c) and of GDNVEKPFAIAKE (d). Inboth experiments cells were labeled with
the anti-GDN antibody. (e andf) Double labeling ofGDN-GLVVMNIT transfected COS-7 cell. (e) Anti-GLVVMNIT antibody to detect
recombinant GDN; (f) anti-s-cyclophilin antibody to detect endogenous s-cyclophilin; (g and h) Double labeling of GDNVEKPFAIAKE
transfected COS-7 cell; (g) anti-GDN antibody to detect recombinant GDN; (h) anti-s-cyclophilin antibody (internal peptide) to detect
endogenous s-cyclophilin. GDN-GLVVMNIT was localized to the Golgi and the ER, whereas GDNVEKPFAIAKE was detected in vesicu-
lar structures that codistributed with endogenous s-cyclophilin (see double-labeling in g and h). Bar: 15 jm.
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121Figure 7 . Codistribution of s-cyclophilin and calreticulin im-
munoreactivity in spreading platelets (a and e), and similar distri-
butions of s-cyclophilin and calsequestrin immunoreactivity in
skeletal muscle (fand g) . Platelets were either double-labeled with
s-cyclophilin (a) and with calreticulin antibody (b), or labeled for
s-cyclophilin alone (c-e) . Both proteins were detected within a
ring-like structure and, although less intensively, towards the pe-
riphery ofactivated platelets . These localizations correspond to the
putative location ofthe dense tubular network in activated platelets.
Arrows point to the edge ofthe platelets . (fand g) s-cyclophilin (f )
and calsequestrin (g) inununoreactivity in frozen sections of em-
bryonic day 20 chick hind limb skeletal muscle . Bar, 10 ),m .
the dense tubular network in activated platelets (Crawford,
1985), the sarcoplasmic reticulum of fast skeletal muscle
(Campbell, 1986), and the pseudopodia of spreading cells .
Platelets were selected because they are devoid ofRER, and
because the unique localization of calcium-releasing or-
ganelles (the dense tubular network) during the activation
process has been described (Crawford, 1985) . As shown in
Fig . 7 (a-e), most s-cyclophilin in spreading platelets was re-
stricted to a ring of immunoreactive material that was also
detected with antibodies against calreticulin . Additional less
intense signal was detectable towards the platelet periphery.
The distribution ofs-cyclophilin and calreticulin was similar
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to the expected distribution ofthe dense tubular network, but
was markedly different from the distribution of most other
membrane-bound structures of platelets. Most membrane-
bound structures, including secretory vesicles, are concen-
trated in the central part of the activated platelet (Crawford,
1985) . Therefore, the distribution of s-cyclophilin in plate-
lets was consistent with it being present in stimulus-sensitive
calcium storage sites.
As mentioned above, we also compared the distributions
of s-cyclophilin and of calsequestrin in skeletal muscle. Cal-
sequestrin is a calcium-binding protein of the sarcoplasmic
reticulum that is particularly enriched in terminal cistemae,
i.e., the ryanodine receptor containing main sites of Cal+
release in skeletal muscle (Campbell, 1986) . As shown in
Fig . 7 (f and g), s-cyclophilin and calsequestrin had similar
distributions . However, the more uniform distribution ofthe
s-cyclophilin signal may indicate that, unlike calsequestrin,
s-cyclophilin is not concentrated in SR-terminal cisternae.
Finally, we determined whether s-cyclophilin-containing
structures were present in pseudopodia of spreading cells, a
specialized cellular region that might be an important site of
calcium-mediated signaling . As shown in Fig. 8, s-cyclo-
philin was clearly present in pseudopodia of spreading L6
cells. s-Cyclophilin-containing organelles therefore appeared
to be widely distributed inside the cell, including several,
and perhaps all peripheral cellular regions and structures .
These peripheral regions frequently appear to contain rela-
tively high amounts ofs-cyclophilin- (and calreticulin-) posi-
tive vesicular structures, possibly reflecting elevated demands
for local calcium-mediated signaling .
Discussion
s-Cyclophilin is an ubiquitous, abundant, and conserved
member ofthe cyclophilin family. Like cytosolic cyclophilin,
s-cyclophilin is a soluble protein that possesses peptidyl-
prolyl cis-trans isomerase activity and that binds to CsA
with high affinity. Unlike its cytosolic counterpart, however,
s-cyclophilin possesses a classical and functional signal se-
quence. We show that most of s-cyclophilin is not secreted,
but is retained in anER compartment . Retention is probably
promoted by an s-cyclophilin-specific COOH-terminal ex-
tension, as this amino acid sequence is sufficient to direct an
otherwise secretory protein to at least a part of the s-cyclo-
philin-containing vesicular structures .
That s-cyclophilin is associated with an ER compartment
is demonstrated by its consistent colocalizationwith calretic-
ulin, a soluble Cal+-binding protein that possesses the ER
retention sequence KDEL and has been shown to copurify
withER markers (Smith and Koch, 1989 ; Krause et al ., 1989 ;
Treves et al., 1990 ; Milner et al ., 1991) . That s-cyclophilin
is localized insideERmembranes is supported by the follow-
ing observations : (a) microsome-associated s-cyclophilin
comigrated with signal peptide-free recombinant s-cyclo-
philin, indicating that it had been previously translocated
across the ERmembrane (Fig . 3 c) ; (b) s-cyclophilin-GLVV
MNIT was retained in the ER (Fig . 6 a), implying that the
signal sequence of s-cyclophilin did direct its translocation
across the ER membrane ; and (c) a minor proportion of
s-cyclophilin was secreted from cells and was recovered in
the extracellular space as a signal peptide-free species . The
latter observation can probably be explained by leakage of
122Figure 8 . s-Cyclophilin containing vesicular structures in pseudopodia of spreading L6 cells . Cells were seeded onto tissue culture plastic,
and allowed to spread for 50 min before fixation . Cells were then double labeled for either s-cyclophilin (a) and the ER (b), or for s-cyclo-
philin (c) and f-actin (d) . Note that s-cyclophilin containing structures were particularly enriched in the vicinity of f-actin rich regions
(arrows in c and d) . Bar, 15 Am .
s-cyclophilin to the constitutive secretory pathway, a phe-
nomenon that was also reported for the KDEL-bearing ER
protein BiP (Pelham, 1989) .
s-Cyclophilin and calreticulin antibodies yielded very
similar labeling patterns, indicating that these proteins may
colocalize throughout the cell . On the other hand, less pre-
cise codistribution was observed between s-cyclophilin and
Cal+ATPase or calsequestrin, suggesting the existence of
differences in the distributions of these proteins within the
ER system . Finally, striking differences were observed when
the distribution of s-cyclophilin immunoreactivity was com-
pared to that of a mixture ofERmembrane proteins . These
variations in the labeling patterns with antibodies to different
ER proteins imply the presence of significant heterogeneity
in the ER system . That some heterogeneity does exist was
demonstrated for cerebellar Purkinje cells in a recent immu-
nocytochemical study at the electron microscopic level
(Villa et al., 1991) . Our spreading cell data (Fig. 8) clearly
show that pseudopods contain significant amounts ofs-cyclo-
philin but little or no ER antigens . On the other hand, it was
not possible to determine whether s-cyclophilin spots in the
perinuclear regionmay correspond to "hot spots" ofthis pro-
tein and calreticulin within theER, or whether they may be-
long to separate, possibly communicating structures . Clear-
ly, our study at the light microscopic level does not provide
the kind ofresolution that would be required to answer these
important questions. Unfortunately, our attempts to study
the distribution of s-cyclophilin at the EM level have failed:
several methods, including cryosection immunogold label-
ing, failed to yield appreciable signals, possibly due to the
particular lability of s-cyclophilin containing structures.
Such lability was reflected in the different sensitivity of the
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vesicular pattern to various permeabilization protocols . As
expected from the prevalently intracellular localization of
s-cyclophilin, no labeling was observed when the antibody
was applied to living cells at 4°C (data not shown) . On the
other hand, while all permeabilization protocols yielded a
punctate labeling pattern to some degree, only a brief ex-
posure to detergent after paraformaldehyde fixation led to
the reproducible, homogeneous distribution of vesicular
structures shown in this work . This sensitivity to permeabil-
ization conditions was characteristic ofthe s-cyclophilin-type
signal : while it was also observed for calreticulin, and to a
lesser extent for Cal+ATPase immunoreactivity, it was not
observed for ER antigens with reticular labeling pattern .
Therefore, while our data point to further heterogeneity in
the ER system, only a corresponding study at the electron
microscopic level will show whether and to what extent these
ER proteins are localized to different ER subcompartments .
Our COOH-terminal substitution experiments demon-
strate that the s-cyclophilin specific tail VEKPFAIAKE can
direct a normally secreted protein to s-cyclophilin contain-
ing, vesicular structures . This finding suggests that the se-
quence VEKPFAIAKE might mediate binding to either an
ER component or to a component of transport vesicles to the
ER . This interaction could be either specific for s-cyclo-
philin, or be shared by additional soluble ER proteins . No
COOH-terminal sequences related to VEKPFAIAKE could
be identified in a database search (Gen/EMBL, April 1991),
and it is therefore presently not possible to determine whether
additional proteins might use this putative binding mecha-
nism . It is, on the other hand, unlikely that the sequence
VEKPFAIAKE may exclusively function as aKDEL substi-
tute, because ofthe documentec, specific requirements of this
123retention mechanism (Pelham, 1989), and because, in that
case, one might have predicted an ERtype distribution of
GDNVEKPFAIAKE immunoreactivity. Finally, GDNVEK-
PFAIAKE was frequently notdetected in peripheralvesicular
structures that were detected with the s-cyclophilin, Cal+-
ATPase, and calreticulin antibodies. While this observation
may be due to comparatively low expression levels of the
recombinant protein, the more central localization ofGDN-
VEKPFAIAKE did not reflect localization of the mutantpro-
tein in the transport vesicles that shuttle between ER and cis-
Golgi: in agreement with the data of Hauri and colleagues
(Schweizer et al., 1988), the G1/93 antigen that specifically
identifies that compartment was detected in densely packed
vesicular structures that were restricted to a narrow and
highly unsymmetrical juxtanuclear region of COS7 cells
(data not shown), whereas GDNVEKPFAIAKE was detected
in comparatively widely spaced vesiclesthat were distributed
over a much larger proportion of the cell .
The localization of s-cyclophilin in an ER compartment
that may not coincide with the RER is unexpected in view
of the proposed function of this protein in protein folding
(Fischer and Schmid, 1990). Our findings may indicate that
s-cyclophilin is not involved in biosynthetic protein folding,
i.e., in the auxiliary reactions that promote proper protein
folding after synthesis, and after membrane translocation of
a polypeptide chain (Rothman, 1989) . While a general pro-
tein folding promoting role of s-cyclophilin in the ER is pos-
sible, our findings are consistent with a specialized role of
cyclophilins in processes involving Cal+ . Such a role is sug-
gested by the actions of CsA on Cal+-mediated processes,
and by the association of s-cyclophilin with Cat+-binding
proteins concentrated within a specialized ER subcompart-
ment. Whether this subcompartment coincides, at least in
part, with calciosomes (Hashimoto et al., 1988 ; Volpe et al .,
1988; Krause et al., 1989; Meldolesi et al., 1990; Koch,
1990) remains to be investigated.
In summary while the function of cyclophilins, including
s-cyclophilin, is presently not clear, our findings point to an
additional potential target for CsA action, and provide a
potentially valuable marker to study protein transport to the
ER and to analyze behavior and heterogeneity of this impor-
tant membrane system.
We are grateful to D. Monard and E. Reinhard (Friedrich Miescher Insti-
tute, Basel, Switzerland; anti-GDN antiserum, and full-length rat GDN
clone), to D. Clegg (University of California, Santa Barbara, CA; anti-
chick calsequestrin antiserum), to D. Louvard (Pasteur Institute, Paris,
France; anti-ER antiserum), and to R. Chiquet-Ehrismann (Friedrich
Miescher Institute, Basel, Switzerland; anti-GLVVMNIT antiserum) for
gifts of reagents, and to A. Villa, P. Podini, and J. Meldolesi (University
ofMilano, Milano, Italy; immuno-electron microscopy experiments), to E.
Cerny (Univ. of Geneva, Geneva, Switzerland; calreticulin and Cal*-
ATPase peptide synthesis), to B. Weisshaar (Friedrich Miescher Institute;
transfection protocol), to D. Reddy (Friedrich Miescher Institute; PCR
strategy), and to J. Hagman (Friedrich Miescher Institute; platelet experi-
ments) for experimental help. We are especially grateful to M. Dihanich,
J. Hagman, H. P. Hauri, F. Meins, and F. Widmer for critically reading
the manuscript.
K. H. Krause was supported bygrant 32-30161 .90ofthe Swiss National
Foundation.
Received for publication 17 June 1991 and in revised form 16 September
1991 .
The Journal of Cell Biology, Volume 116, 1992
References
Bole, D. G., L. M . Hendershot, and J . F. Kearney. 1986. Posttranslational as-
sociationofimmunoglobulin heavy chain bindingproteinwith nascent heavy
chains in nonsecreting hybridomas. J. Cell Biol. 102:1558-1566.
Brown, W. J., J. Goodhouse, and M. G. Farquhar. 1986. Mannose-6-
phosphate receptors forlysosomalenzymes cycle betweenthe Golgicomplex
and endosomes. J. Cell Biol. 103:1235-1247.
Burgoyne, R. D., T. R. Cheek, A. Morgan, A. J. O'Sullivan, R. B. Moreton,
M. J. Berridge, A. M. Mata, J. Colyer, A. G. Lee, and J. M. East. 1989.
Distribution of two distinct Cal*-ATPase-like proteins and their relation-
ships to the agonist-sensitive calcium store in adrenal chromaffin cells. Na-
ture (Lond.). 342:72-74.
Campbell, K. P. 1986. Protein componentsandtheir roles insarcoplasmic retic-
ulum function. In SarcoplasmicReticulum in Muscle Physiology. M. L. Ent-
man and W. B. Van Winkle, editors. CRC Press, Boca Raton, FL. 65-92.
Caroni, P., A. Rothenfluh, E. McGlynn, and C. Schneider. 1991 . S-cyclo-
philin. New member ofthe cyclophilin family associated with the secretory
pathway. J. Biol. Chem. 266:10739-10742.
Chen, C., and H. Okayama. 1987. High-efficiency transformation of mam-
malian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
Choi, E. S. H., and D. O. Clegg. 1990. Identification and developmental ex-
pression of a chicken calsequestrin homolog. Dev. Biol. 142:169-177.
Cirillo, R., M. Triggiani, L. Siri, A. Ciccarelli, G. R. Pettit, M. Condorelli,
and G. Marone. 1990. Cyclosporin A rapidly inhibits mediator release from
human basophils, presumably by interacting with cyclophilin. J. Immunol.
144:3891-3897.
Crawford, N. 1985. Structure and organization of platelet membranes. Adv.
Exp. Med. Biol. 192:1-13.
Dawson, A. P. 1982. Kinetic properties ofthe Cal*-accumulation system ofa
rat liver microsomal fraction. Biochem. J. 206:73-79.
Doolittle, R. F. 1986. OfURFS and ORFS. Aprimeronhow to analyzederived
amino acid sequences. University Science Books. Mill Valley, CA. 89-90.
Ellis, L., E. Clauser, D. O. Morgan, M. Edery, R. A. Roth, and W. J. Rutter.
1986. Replacementofinsulin receptortyrosine residues 1162 and 1163 com-
promises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.
Cell. 45:721-732.
Fischer, G., B. Winmann-Liebhold, T. Kiethaber, F. X. Schmid, andK. Lang.
1989. Cyclophilin andpeptidyl-prolyl cis-trans isomerase are probably iden-
tical proteins. Nature (Load.). 337:476-478.
Fischer, G., and F. X. Schmid. 1990. The mechanism ofprotein folding. Impli-
cationsofinvitrorefoldingmodels fordenovo protein folding and transloca-
tion in the cell. Biochemistry. 29:2205-2212.
Fliegel, L., M. Ohnishi, M. R. Carpenter,V. K. Khanna, R. A. F. Reithmeier,
and D. H. McLennan. 1987. Aminoacid sequence ofrabbitfast-twitch skele-
tal muscle calsequestrin deduced from cDNA and peptide sequencing. Proc.
Natl. Acad. Sci. USA. 84:1167-1171.
Guenther, J., H. Nick, and D. Monard. 1985. A glia-derived neurite-promoting
factor with protease inhibitory activity. EMBO (Eur. Mol. Biol. Organ.) J.
4:1963-1966.
Halestrap, A. P., and A. M. Davidson. 1990. Inhibition of Cal'-induced
large-amplitude swelling of liver and heart mitochondria by Cyclosporin A
is probably causedby the inhibitor bindingto mitochondrial-matrix peptidyl-
prolyl cis-trans isomerase and preventing it interacting with the adenine
nucleotide translocase. Biochem. J. 268:153-160.
Halfter, W., E. Reinhard, D. Liverani, R. Ortman, and D. Monard. 1989. Im-
munocytochemical localization ofglia-derived nexin, laminin and fibronec-
tin on the surface or extracellular matrix of C6 rat glioma cells, astrocytes
and fibroblasts. Eur. J. Neurosci. 1:297-308.
Hasan, N., and N. Szybalski. 1987. Control ofcloned gene expression by pro-
moter inversion in vivo: construction of improved vectors with a multiple
cloning site and the p. promoter. Gene. 56:145-151 .
Hasel, K. W., J. R. Glass, M. Godbout, and J. G. Sutcliffe. 1991 . An endoplas-
mic Rticulum-specific cyclophilin. Mol. Cell. Biol. 11:3484-3491.
Hashimoto, S., B. Bruno, D. P. Lew, T. Pozzan, P. Volpe, and J. Meldolesi.
1988. Immunocytochemistry of calciosomes in liver and pancreas. J. Cell
Biol. 107:2524-2531 .
Hohman, R. J., andT. Hultsch. 1990. Cyclosporin A: new insights for cell biol-
ogists and biochemists. New Biologist. 2:663-672.
Hultsch, T., J. L. Rodriquez, M. A. Kaliner, and R. J. Hohman. 1990. Cy-
closporin A inhibits degranulationofrat basophilic leukemiacells and human
basophils. Inhibition of mediator release without affecting PI hydrolysis or
Call fluxes. J. Immunol. 144:2659-2664.
Iwai, N., and T. Inagami. 1990. Molecular cloning or complementary DNA
to rat cyclophilin-like protein mRNA. Kidney Intl. 37:1460-1465.
Jorgensen, A. O., A. C.-Y. Shen, K. P. Campbell, and D. H. MacLennan.
1983. Ultrastructural localization of calsequestrin in rat skeletal muscle by
immunoferritin labeling ofultrathin frozen sections. J. Cell Biol. 97:1573-
1581 .
Kaprielian, Z., A. M. Campbell, and D. M. Fambrough. 1989. Identification
of a CaZ*-ATPase in cerebellar Purkinje cells. Mol. Brain Res. 6:55-60.
Koch, G. L. E. 1990. The endoplasmic reticulum and calcium storage. BioEs-
says. 1 :527-532.
124Koser, P. L., D. Sylvester, G. P. Livi, and D. J. Bergsma. 1990. A second
cyclophilin-related gene in Saccharomyces cerevisiae. Nucl. Acids Res. 18:
1643.
Krause, K. H., D. Pittet, P. Volpe, T. Pozzan, J. Meldolesi, and D. P. Lew.
1989. Calciosomes, a sarcoplasmic reticulum-like organelle involved in in-
tracellular calcium handling by non-muscle cells. Studies in human neutro-
phils and HL60 cells. Cell Calcium. 10:351-361.
Louvard, D., H. Reggio, and G. Warren. 1982. Antibodies to the Golgi com-
plex and rough endoplasmic reticulum. J. Cell Biol. 92:92-107.
Mattila, P. S., K. S. Ullman, S. Fiering, E. A. Emmel, M. McCutcheon, G. R.
Crabtree, and L. Herzenberg. 1990. The actions ofcyclosporin A and FK506
suggest a novel step in the activation of T lymphocytes. EMBO (Eur. Mol.
Biol. Organ.) J. 9:4425-4433.
McGuiness, O., N. Yafei, A. Cosh, and M. Crompton. 1990. The presence
of two classes of high-affinity cyclosporin A binding sites in mitochondria.
Evidence that the minor component is involved in the opening of an inner-
membrane Ca2`dependent pore. Eur. J. Biochem. 194:671-679.
Meldolesi, J., L. Madeddu, and T. Pozzan. 1990. Intracellular Cal* storage
organelles in non-muscle cells: heterogeneity and functional assignment.
Biochem. Biophys. Acta. 1055:130-140.
Milner, R. E., S. Baksh, C. Shemanko, M. R. Carpenter, L. Smillie, J. E.
Vance, M. Opas, and M. Michalak. 1991. Calreticulin, and not calseques-
trin, is the major calcium binding protein of smooth muscle sarcoplasmic
reticulum and liverendoplasmic reticulum. J. Biol. Chem. 266:7155-7163.
Munro, S., and H. R. B. Pelham. 1987. A C-terminal signal prevents secretion
of luminal ER proteins. Cell. 48:899-907.
Pelham, H. R. B. 1989. Control ofprotein exitfrom theendoplasmic reticulum.
Annu. Rev. Cell Biol. 5:1-23.
Price, I. R., L. D. Zydovsky, Z. Dowesky, M. Jin, C. H. Baker, F. D.
McKeon, and C. T. Walsh. 1991. Humancyclophilinb: a secondcyclophilin
geneencodes a peptidyl-prolyl isomerasewitha signal sequence. Proc. Nad.
Acad. Sci. USA. 88:1903-1907.
Rothman, J. E. 1989. Polypeptide chain binding proteins: catalysts ofprotein
folding and related processes in cells. Cell. 59:591-601 .
Schafner, W., and C. Weissman. 1973. A rapid, sensitive, and specific method
for the determination of protein in dilute solution. Anal. Biochem. 56:
502-514.
Schneuwly, S., R. D. Shortridge, D. C. Larrivee, T. Ono, M. Ozaki,andW. L.
Pak. 1989. DrosophilaninaAgeneencodes aneye-specific cyclophilin (cyclo-
sporine A binding protein). Proc. Narl. Acad. Sci. USA. 86:5390-5394.
Schweizer, A.,J. A. M. Fransen, T. Baechi, L. Ginsel, and H.-P. Hauri. 1988.
Identification, by a monoclonal antibody, of a 53-kD protein associatedwith
atubulo-vesicular compartmentatthe cis-sideofthe Golgi apparatus. J. Cell
Biol. 107:1646-1659.
Schweizer, F. E., T. Schaefer, C. Tapparelli, M. Grob, U. O. Karli, R. Heu-
mamr, H. Thoenen, R. J. Brockman, and M. M. Burger. 1989. Inhibition
of exocytosis by intracellularly applied antibodies against a chromaffin
granule-binding protein. Nature (Load.). 339:709-712.
Arber et al. Ubiquitous ER Protein s-Cyclophilin
Shieh, B.-H., M. A. Stamnes, S. Seavello, G. L. Harris, and C. S. Zuker.
1989. TheninaA generequired for visual transduction in Drosophila encodes
a homologue of cyclosporin A-binding protein. Nature (Load.). 338:67-70.
Smith, M. J., and G. L. E. Koch. 1989. Multiple zones in the sequence of cal-
reticulin (CRP55, calregulin, HACBP),amajorcalciumbinding ER/SRpro-
tein. EMBO (Eur. Mol. Biol. Organ.) J. 8:3581-3586.
Spik, G., B. Haendler, O. Delmas, C. Mariller, M. Chamoux, P. Maes, A.
Tartar, J. Montreuil, K. Stedman, H. P. Kocher, R. Keller, P. C. Hiestand,
and N. R. Movva. 1991. A novel, secreted, cyclophilin-like protein
(SCYLP). J. Biol. Chem. 266:10735-10738.
Stamnes, M. A., and C. S. Zuker. 1990. Peptidyl-prolyl cis-trans isomerases,
cyclophilin, FK506-binding protein, and ninaA: four ofa kind. Curr. Biol.
2:1104-1107.
Stamnes, M. A., B.-H. Shieh, L. Chuman, G. L. Harris, and C. S. Zuker.
1991. Thecyclophilin homolog ninaA is a tissue-specific integral membrane
protein required for the proper synthesis of a subset of Drosophila rhodop-
sins. Cell. 65:219-227.
Standaert, R. F., A. Galat, G. L. Verdine, and S. L. Schreiber. 1990. Molecu-
lar cloning and overexpression of the human FK506-binding protein FKBP.
Nature (Load.). 346:671-674.
Swanson, J. A., B. D. Yirinec, and S. C. Silverstein. 1985. Phorbol esters and
horseradishperoxidase stimulatepinocytosis andredirectthe flow of pinocy-
tosed fluid in macrophages. J. Cell Biol. 100:851-859.
Takahashi, N., H. Toshiya, and M. Suzuki. 1989. Peptidyl-prolyl cis-trans
isomerase is the cyclosporin A-binding protein cyclophilin. Nature (Load.).
337:473-475.
Trenn, G., R. Taffs, R. Hohman, R. Kincaid, E. M. Shevach, and M. Sit-
kovsky. 1989. Biochemical characterization ofthe inhibitory effect of C&A
on cytolytic T lymphocyte effector functions. J. Immunol. 142:3796-3802.
Treves, S., M. DeMattei, M. Lanfredi, A. Villa, N. M. Green, D. H. MacLen-
nan, J. Meldolesi, and T. Pozzan. 1990. Calreticulin is a candidate for a
calsequestrin-like function in Ca'*-storage compartments (calciosomes) of
liver and brain. Biochem. J. 272:473-480.
Tropschug, M., D. W. Nicholson, F.-U. Hard, H. Koehler, N. Pfanner, E.
Wachter, and W. Neupert. 1988. Cyclosporin A-binding protein (cyclo-
philin) ofNeurospora crassa. Onegenecodes forboththe cytosolic andmito-
chondrial forms. J. Biol. Chem. 263:14433-14440.
Tropschug, M., E. Wachter, S. Mayer, E. R. Schoenbrunner, and F. X.
Schmid. 1990. Isolation and sequence of an FK506-bindingprotein from N.
crassa which catalyses protein folding. Nature (Load.). 346:674-677.
Villa, A., P. Podini, D. O. Clegg, T. Pozzan, andJ. Meldolesi. 1991. Intracel-
lular Ca'* stores in chicken Purkinje neurons: differential distribution ofthe
low affinity-high capacity Cat*-binding protein, calsequestrin, of Ca2*-
ATPase and of the ER lumenal protein, BiP. J. Cell Biol. 113:779-791 .
Volpe P, K. H. Krause, S. Hashimoto, F. Zorzato, T. Pozzan, J. Meldolesi,
and D. P. Lew. 1988. "Calciosome" a cytoplasmic organelle: the inositol
1,4,5-triphosphate-sensitive Cal* store of nonmuscle cells? Proc. Nad.
Acad. Sci. USA. 85:1091-1095.
125